ADVERSE DRUG-REACTIONS LEADING TO HOSPITAL ADMISSION

被引:33
作者
IBANEZ, L [1 ]
LAPORTE, JR [1 ]
CARNE, X [1 ]
机构
[1] UNIV AUTONOMA BARCELONA,HOSP UNIV VALL DHEBRON,SERV FARMACOL CLIN,UNITAT FARMACOL CLIN,E-08035 BARCELONA,SPAIN
关键词
D O I
10.2165/00002018-199106060-00005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This article describes the implementation of a simple method of drug surveillance set up at a hospital emergency ward. From a total of 48 678 patients admitted, the medical records of those presenting with one or more of a pre-established list of admission diagnoses (n = 7728; 15.8%) were checked. Of these 554 (1.1%) were diagnosed as experiencing an adverse drug reaction. When the medical record suggested an adverse drug reaction, drugs taken before admission were ascertained by interviewing the patients with a structured questionnaire. After excluding upper gastrointestinal bleeding (226 cases) and certain bone marrow blood dyscrasias (42 cases), 286 patients with drug-induced events leading to hospital admission were identified in 2 years. Fatal adverse drug reactions, previously undescribed reactions, and some specific examples, such as digoxin-amiodarone interaction, drug-induced pancreatitis, nicardipine-induced AV block, severe skin reactions, and NSAID-induced bronchospasm, are described. Basically, this method consists of assembling series of cases systematically, and is therefore devoid of selective bias. In addition, it allows a more indepth clinical and anamnesic study of specific diseases, as compared with voluntary reporting.
引用
收藏
页码:450 / 459
页数:10
相关论文
共 45 条
[1]  
Agre K., An overview of the safety and efficacy of nicardipine in clinical trials, American Journal of Cardiology, 59, (1987)
[2]  
Armadans L., Carne X., Laporte J.R., Detección de reacciones adversas a medicamentos a partir del diagnóstico de ingreso hospitalario: métpdo y resultados, Medicina Clinica (Barcelona), 91, pp. 124-127, (1988)
[3]  
Banerjee A.K., Patel K.J., Grainger S.L., Drug-induced acute pancreatitis: a critical review, Medical Toxicology and Adverse Drug Experience, 4, pp. 186-198, (1989)
[4]  
Bianchine J.R., Macaraeg P.V.J., Lasagna L., Azarnoff D.L., Brunk S.F., Et al., Drugs as etiologic factors in the Stevens-Johnson syndrome, American Journal of Medicine, 44, pp. 390-405, (1968)
[5]  
Borda I.T., Slone D., Jick H., Assessment of adverse drug reactions within a drug surveillance program, Journal of the American Medical Association, 205, pp. 99-101, (1968)
[6]  
Bottiger L.E., Strandberg I., Westerholm B., Drug-induced febrile muco-cutaneous syndrome: with a survey of the literature, Acta Medica Scandinavica, 198, pp. 229-233, (1975)
[7]  
Capella D., Avila P., Cabeza L., Moreno V., Vidal X., Et al., Cuatro años de experiencia en farmacovigilancia, Medicina Clínica (Barcelona), 91, pp. 93-96, (1988)
[8]  
Capella D., Laporte J.R., Castel J.M., Tristan C., Cos A., Et al., Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine, British Medical Journal, 297, pp. 722-723, (1988)
[9]  
Caranassos G.I., Stewart R.B., Cluff L.E., Drug-induced illness leading to hospitalization, Journal of the American Medical Association, 228, pp. 713-717, (1974)
[10]  
Davies D.M., Disorders of metabolism II, Textbook of adverse drug reactions, pp. 370-454, (1986)